Furthermore, fenofibrate decreases leptin levels in animal models of obesity (34, 35, 36) and decreases leptin secretion by adipose cell cultures from dyslipidemic but not from normolipidemic humans (37). This evidence concerns the gene LEP and obesity disorder.